{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T07:51:45Z","timestamp":1781769105267,"version":"3.54.5"},"reference-count":58,"publisher":"Ovid Technologies (Wolters Kluwer Health)","license":[{"start":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T00:00:00Z","timestamp":1781654400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>C-terminal carboxy-truncated hepatitis B virus X (Ct-HBx) exerts its hepatocarcinogenic effects, at least in part, through the upregulation of plasminogen activator inhibitor-1 (PAI-1). This study aimed to explore the mechanisms by which Ct-HBx upregulates PAI-1 and determine the effects of PAI-1 functional polymorphisms and expression on the development of hepatitis B virus-related hepatocellular carcinoma (HBV-HCC).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Method:<\/jats:title>\n                    <jats:p>\n                      Transposase-accessible chromatin sequencing was performed to identify chromatin accessibility induced by wild-type HBx (WT-HBx) and Ct-HBx. Functional polymorphisms of\n                      <jats:italic toggle=\"yes\">PAI-1<\/jats:italic>\n                      and their association with HBV mutations and HCC risk were evaluated in 3472 participants. PAI-1 in the HBV-infected cohort was measured using enzyme-linked immunosorbent assay. Associations between functional polymorphisms, serum PAI-1 levels, and postoperative prognosis in HBV-HCC were assessed in two cohort studies.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      Compared with WT-HBx, Ct-HBx upregulated the expression of histone acetyltransferases and chromatin-remodeling factors, thereby increasing the chromatin accessibility of the \u20131kb promoter and the 3\u2032-untranslated region (3\u2032UTR) of\n                      <jats:italic toggle=\"yes\">PAI-1<\/jats:italic>\n                      and promoting PAI-1 expression. rs2227631-G at the promoter and the rs11178-T and 1050955-A at the 3\u2032UTR of\n                      <jats:italic toggle=\"yes\">PAI-1<\/jats:italic>\n                      were significantly associated with an increased risk of HCC. The polymorphic genotypes predisposing to higher PAI-1 expression were often associated with higher frequencies of HCC-risk HBV mutations. The interaction between these polymorphic genotypes and the HBV mutations greatly increased HBV-HCC risk. Serum concentration of PAI-1 increased progressively during HBV-induced hepatocarcinogenesis. rs2227631-GG and rs11178-TT genotypes, along with higher PAI-1 expression, were risk factors for poor postoperative prognosis in HBV-HCC.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>Ct-HBx upregulates PAI-1 expression by increasing chromatin accessibility. Functional polymorphic genotypes that facilitate PAI-1 expression and their interactions with HCC-risk HBV mutations promote HBV-HCC. PAI-1 is a novel prognostic and predictive factor for HBV-HCC.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/cm9.0000000000004121","type":"journal-article","created":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T07:00:16Z","timestamp":1781766016000},"update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Effect of plasminogen activator inhibitor-1 transcriptionally upregulated by C-terminal truncated hepatitis B virus X on the development of hepatocellular carcinoma"],"prefix":"10.1097","author":[{"given":"Jiayi","family":"Zhao","sequence":"first","affiliation":[{"name":"Department of Epidemiology, Second Military Medical University, Shanghai 200433, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yifan","family":"Chen","sequence":"additional","affiliation":[{"name":"Key Laboratory of Biological Defense, Ministry of Education, Second Military Medical University, Shanghai 200433, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Pu","sequence":"additional","affiliation":[{"name":"Shanghai Key Laboratory of Medical Bioprotection, Second Military Medical University, Shanghai 200433, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenbin","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, Second Military Medical University, Shanghai 200433, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, Second Military Medical University, Shanghai 200433, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zishuai","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, Second Military Medical University, Shanghai 200433, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Zhao","sequence":"additional","affiliation":[{"name":"Department of Liver Cancer Surgery, The Third Affiliated Hospital of Second Military Medical University, Shanghai 200433, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangwen","family":"Cao","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, Second Military Medical University, Shanghai 200433, China"},{"name":"Key Laboratory of Biological Defense, Ministry of Education, Second Military Medical University, Shanghai 200433, China"},{"name":"Shanghai Key Laboratory of Medical Bioprotection, Second Military Medical University, Shanghai 200433, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,6,17]]},"reference":[{"key":"R1-20260618","doi-asserted-by":"crossref","first-page":"3457","DOI":"10.1097\/CM9.0000000000003787","article-title":"Global epidemiology of liver cancer burden due to hepatitis B virus:A comprehensive estimate based on Global Burden of Disease Study 2021","volume":"138","author":"Cao","year":"2025","journal-title":"Chin Med J"},{"key":"R2-20260618","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1002\/cac2.12195","article-title":"Trends in cancer mortality in China from 2004 to 2018:A nationwide longitudinal study","volume":"41","author":"Jiang","year":"2021","journal-title":"Cancer Commun (Lond)"},{"key":"R3-20260618","article-title":"Epidemiological characteristics of primary liver cancer in Mainland China from 2003 to 2020:A representative multicenter study","volume":"12","author":"Lin","year":"2022","journal-title":"Front Oncol"},{"key":"R4-20260618","first-page":"38","article-title":"Impact of occult hepatitis B virus infection and high-fat diet on hepatocellular carcinoma development","volume":"10","author":"Chen","year":"2024","journal-title":"Hepatoma Res"},{"key":"R5-20260618","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1038\/sj.onc.1206889","article-title":"Characterization of HBV integrants in 14 hepatocellular carcinomas:Association of truncated X gene and hepatocellular carcinogenesis","volume":"23","author":"Wang","year":"2004","journal-title":"Oncogene"},{"key":"R6-20260618","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1038\/s41388-020-01593-5","article-title":"C-terminal truncated HBx initiates hepatocarcinogenesis by downregulating TXNIP and reprogramming glucose metabolism","volume":"40","author":"Zhang","year":"2021","journal-title":"Oncogene"},{"key":"R7-20260618","doi-asserted-by":"crossref","first-page":"3647","DOI":"10.1200\/JCO.2012.48.5896","article-title":"Effect of antiviral treatment with nucleotide\/nucleoside analogs on postoperative prognosis of hepatitis B virus-related hepatocellular carcinoma:A two-stage longitudinal clinical study","volume":"31","author":"Yin","year":"2013","journal-title":"J Clin Oncol"},{"key":"R8-20260618","first-page":"5","article-title":"Epidemiological characteristics and precise prophylaxis and control of HBV-associated primary liver cancer","volume":"11","author":"Feng","year":"2025","journal-title":"Hepatoma Res."},{"key":"R9-20260618","doi-asserted-by":"crossref","first-page":"2821","DOI":"10.1097\/CM9.0000000000003178","article-title":"Current trends and advances in antiviral therapy for chronic hepatitis B","volume":"137","author":"Li","year":"2024","journal-title":"Chin Med J"},{"key":"R10-20260618","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.836517","article-title":"The effects and underlying mechanisms of hepatitis B virus X gene mutants on the development of hepatocellular carcinoma","volume":"12","author":"Pu","year":"2022","journal-title":"Front Oncol"},{"key":"R11-20260618","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/j.cmet.2024.03.002","article-title":"Cardiometabolic characteristics of people with metabolically healthy and unhealthy obesity","volume":"36","author":"Petersen","year":"2024","journal-title":"Cell Metab"},{"key":"R12-20260618","doi-asserted-by":"crossref","first-page":"10168","DOI":"10.1038\/s41467-025-65259-0","article-title":"Hexokinase 2-mediated histone H3K18la promotes PAI-1-dependent thrombosis in acute myeloid leukemia via tumor-endothelial crosstalk","volume":"16","author":"Bai","year":"2025","journal-title":"Nat Commun"},{"key":"R13-20260618","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1002\/ajh.27222","article-title":"Inherited thrombophilia gene mutations and risk of venous thromboembolism in patients with cancer:A systematic review and meta-analysis","volume":"99","author":"Roy","year":"2024","journal-title":"Am J Hematol"},{"key":"R14-20260618","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1158\/1541-7786.MCR-13-0543","article-title":"PAI-1 leads to G1-phase cell-cycle progression through cyclin D3\/cdk4\/6 upregulation","volume":"12","author":"Giacoia","year":"2014","journal-title":"Mol Cancer Res"},{"key":"R15-20260618","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1096\/fj.201700237RR","article-title":"Endothelial cells promote triple-negative breast cancer cell metastasis via PAI-1 and CCL5 signaling","volume":"32","author":"Zhang","year":"2018","journal-title":"FASEB J"},{"key":"R16-20260618","doi-asserted-by":"crossref","first-page":"2177","DOI":"10.1016\/j.celrep.2018.10.082","article-title":"Plasminogen activator inhibitor-1 promotes the recruitment and polarization of macrophages in cancer","volume":"25","author":"Kubala","year":"2018","journal-title":"Cell Rep"},{"key":"R17-20260618","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2023.216117","article-title":"Good or bad:Paradox of plasminogen activator inhibitor 1 (PAI-1) in digestive system tumors","volume":"559","author":"Wang","year":"2023","journal-title":"Cancer Lett"},{"key":"R18-20260618","doi-asserted-by":"crossref","first-page":"4943","DOI":"10.3390\/ijms24054943","article-title":"Association of SNPs in the PAI1 gene with disease recurrence and clinical outcome in bladder cancer","volume":"24","author":"Murakami","year":"2023","journal-title":"Int J Mol Sci"},{"key":"R19-20260618","doi-asserted-by":"crossref","first-page":"4248","DOI":"10.1002\/cncr.25213","article-title":"SERPINE1 intron polymorphisms affecting gene expression are associated with diffuse-type gastric cancer susceptibility","volume":"116","author":"Ju","year":"2010","journal-title":"Cancer"},{"key":"R20-20260618","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s10549-007-9635-3","article-title":"PAI-1 -675 4G\/5G polymorphism as a prognostic biomarker in breast cancer","volume":"109","author":"Lei","year":"2008","journal-title":"Breast Cancer Res Treat"},{"key":"R21-20260618","doi-asserted-by":"crossref","first-page":"2947","DOI":"10.4103\/0366-6999.247211","article-title":"Plasminogen activator inhibitor 1 as a poor prognostic indicator in resectable pancreatic ductal adenocarcinoma","volume":"131","author":"Liu","year":"2018","journal-title":"Chin Med J"},{"key":"R22-20260618","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1097\/CM9.0000000000002316","article-title":"PAI-1 genetic polymorphisms influence septic patients\u2019 outcomes by regulating neutrophil activity","volume":"136","author":"Jiang","year":"2023","journal-title":"Chin Med J"},{"key":"R23-20260618","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1186\/s12902-021-00837-z","article-title":"The susceptibility of SERPINE1 rs1799889 SNP in diabetic vascular complications:a meta-analysis of fifty-one case-control studies","volume":"21","author":"Chen","year":"2021","journal-title":"BMC Endocr Disord"},{"key":"R24-20260618","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1080\/08916934.2019.1700957","article-title":"The -675 4G\/5G PAI-1 polymorphism confers genetic susceptibility to systemic lupus erythematosus, its clinical manifestations, and comorbidities in Mexican-Mestizo population","volume":"53","author":"Anaya-Macias","year":"2020","journal-title":"Autoimmunity"},{"key":"R25-20260618","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1007\/s13760-021-01843-7","article-title":"Association between plasminogen activator inhibitor-1 gene polymorphisms and susceptibility to Parkinson\u2019s disease in Chinese patients","volume":"122","author":"Xu","year":"2022","journal-title":"Acta Neurol Belg"},{"key":"R26-20260618","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/j.fertnstert.2013.11.015","article-title":"Association of five common polymorphisms in the plasminogen activator inhibitor-1 gene with primary ovarian insufficiency","volume":"101","author":"Jeon","year":"2014","journal-title":"Fertil Steril"},{"key":"R27-20260618","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.2147\/OTT.S83723","article-title":"Genetic polymorphisms of PAI-1 and PAR-1 are associated with acute normal tissue toxicity in Chinese rectal cancer patients treated with pelvic radiotherapy","volume":"8","author":"Zhang","year":"2015","journal-title":"Onco Targets Ther"},{"key":"R28-20260618","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1186\/1471-2474-12-160","article-title":"Significant associations of PAI-1 genetic polymorphisms with osteonecrosis of the femoral head","volume":"12","author":"Kim","year":"2011","journal-title":"BMC Musculoskelet Disord"},{"key":"R29-20260618","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.3390\/jpm11121378","article-title":"Association of polymorphisms in plasminogen activator inhibitor-1 (PAI-1), tissue plasminogen activator (tPA), and renin (REN) with recurrent pregnancy loss in Korean women","volume":"11","author":"Cho","year":"2021","journal-title":"J Pers Med"},{"key":"R30-20260618","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2024.110519","article-title":"Androgen receptor-induced molecules and androgen contribute synergistically to male-predominance of hepatocellular carcinoma","volume":"27","author":"Zhao","year":"2024","journal-title":"iScience"},{"key":"R31-20260618","doi-asserted-by":"crossref","first-page":"5525","DOI":"10.1158\/1078-0432.CCR-18-3083","article-title":"Genetic polymorphisms predisposing the interleukin 6-induced APOBEC3B-UNG imbalance increase HCC risk via promoting the generation of APOBEC-signature HBV mutations","volume":"25","author":"Liu","year":"2019","journal-title":"Clin Cancer Res"},{"key":"R32-20260618","first-page":"8","article-title":"Association of human leukocyte antigen-DR-DQ-DP haplotypes with the risk of hepatitis B virus-related hepatocellular carcinoma","volume":"8","author":"Chen","year":"2022","journal-title":"Hepatoma Res"},{"key":"R33-20260618","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1038\/ajg.2010.399","article-title":"Association between the various mutations in viral core promoter region to different stages of hepatitis B, ranging of asymptomatic carrier state to hepatocellular carcinoma","volume":"106","author":"Yin","year":"2011","journal-title":"Am J Gastroenterol"},{"key":"R34-20260618","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1007\/s00535-010-0253-1","article-title":"Significant association of different preS mutations with hepatitis B-related cirrhosis or hepatocellular carcinoma","volume":"45","author":"Yin","year":"2010","journal-title":"J Gastroenterol"},{"key":"R35-20260618","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1007\/s11684-010-0160-0","article-title":"Association of novel mutations and haplotypes in the preS region of hepatitis B virus with hepatocellular carcinoma","volume":"4","author":"Xie","year":"2010","journal-title":"Front Med China"},{"key":"R36-20260618","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2024.107744","article-title":"KAT tales:Functions of Gcn5 and PCAF lysine acetyltransferases in SAGA and ATAC","volume":"300","author":"Dent","year":"2024","journal-title":"J Biol Chem"},{"key":"R37-20260618","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gkae1120","article-title":"ATAC and SAGA histone acetyltransferase modules facilitate transcription factor binding to nucleosomes independent of their acetylation activity","volume":"53","author":"Chesnutt","year":"2025","journal-title":"Nucleic Acids Res"},{"key":"R38-20260618","doi-asserted-by":"crossref","first-page":"19975","DOI":"10.1073\/pnas.0908365106","article-title":"Nuclear HBx binds the HBV minichromosome and modifies the epigenetic regulation of cccDNA function","volume":"106","author":"Belloni","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R39-20260618","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aax0021","article-title":"Deficient histone H3 propionylation by BRPF1-KAT6 complexes in neurodevelopmental disorders and cancer","volume":"6","author":"Yan","year":"2020","journal-title":"Sci Adv"},{"key":"R40-20260618","doi-asserted-by":"crossref","first-page":"3593","DOI":"10.1038\/s41388-021-01804-7","article-title":"Multiple interactions of the oncoprotein transcription factor MYC with the SWI\/SNF chromatin remodeler","volume":"40","author":"Woodley","year":"2021","journal-title":"Oncogene"},{"key":"R41-20260618","doi-asserted-by":"crossref","first-page":"3486","DOI":"10.1007\/s11427-025-3154-3","article-title":"The SWI\/SNF complex mediated chromatin remodeling promotes hepatitis B virus cccDNA transcription","volume":"68","author":"Yuan","year":"2025","journal-title":"Sci China Life Sci"},{"key":"R42-20260618","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1080\/22221751.2019.1666661","article-title":"Chromatin remodelling factor BAF155 protects hepatitis B virus X protein (HBx) from ubiquitin-independent proteasomal degradation","volume":"8","author":"Chen","year":"2019","journal-title":"Emerg Microbes Infect"},{"key":"R43-20260618","doi-asserted-by":"crossref","first-page":"3485","DOI":"10.1038\/s41467-022-31194-7","article-title":"The chromatin remodeller ATRX facilitates diverse nuclear processes, in a stochastic manner, in both heterochromatin and euchromatin","volume":"13","author":"Truch","year":"2022","journal-title":"Nat Commun"},{"key":"R44-20260618","first-page":"12","article-title":"Epigenetic mechanisms in hepatitis B virus-associated hepatocellular carcinoma","volume":"7","author":"Andrisani","year":"2021","journal-title":"Hepatoma Res"},{"key":"R45-20260618","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.canlet.2019.11.043","article-title":"Acetylation of alpha-fetoprotein promotes hepatocellular carcinoma progression","volume":"471","author":"Xue","year":"2020","journal-title":"Cancer Lett"},{"key":"R46-20260618","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1038\/s41419-022-04563-9","article-title":"HBx increases chromatin accessibility and ETV4 expression to regulate dishevelled-2 and promote HCC progression","volume":"13","author":"Zheng","year":"2022","journal-title":"Cell Death Dis"},{"key":"R47-20260618","doi-asserted-by":"crossref","first-page":"12202","DOI":"10.1016\/S0021-9258(19)49825-6","article-title":"Regulatory sequences and protein-binding sites involved in the expression of the rat plasminogen activator inhibitor-1 gene","volume":"267","author":"Johnson","year":"1992","journal-title":"J Biol Chem"},{"key":"R48-20260618","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1182\/blood.V94.6.2029","article-title":"Fibrin fragment induction of plasminogen activator inhibitor transcription is mediated by activator protein-1 through a highly conserved element","volume":"94","author":"Olman","year":"1999","journal-title":"Blood"},{"key":"R49-20260618","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1042\/bj3490435","article-title":"Sp1-like activity mediates angiotensin-II-induced plasminogen-activator inhibitor type-1 (PAI-1) gene expression in mesangial cells","volume":"349","author":"Motojima","year":"2000","journal-title":"Biochem J"},{"key":"R50-20260618","doi-asserted-by":"crossref","first-page":"539","DOI":"10.3350\/cmh.2024.0060","article-title":"Novel role of MHC class II transactivator in hepatitis B virus replication and viral counteraction","volume":"30","author":"Dezhbord","year":"2024","journal-title":"Clin Mol Hepatol"},{"key":"R51-20260618","doi-asserted-by":"crossref","DOI":"10.1128\/jvi.01581-24","article-title":"Identification and characterization of host factor VCPIP1 as a multi-functional positive regulator of hepatitis B virus","volume":"98","author":"Kang","year":"2024","journal-title":"J Virol"},{"key":"R52-20260618","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1002\/hep.29316","article-title":"Hepatitis B virus X protein-elevated MSL2 modulates hepatitis B virus covalently closed circular DNA by inducing degradation of APOBEC3B to enhance hepatocarcinogenesis","volume":"66","author":"Gao","year":"2017","journal-title":"Hepatology"},{"key":"R53-20260618","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1158\/1940-6207.CAPR-15-0160","article-title":"Hepatitis B virus combo mutations improve the prediction and active prophylaxis of hepatocellular carcinoma:A clinic-based cohort study","volume":"8","author":"Yin","year":"2015","journal-title":"Cancer Prev Res (Phila)"},{"key":"R54-20260618","first-page":"9","article-title":"Surveillance for patients at risk of hepatocellular carcinoma:how to improve its cost-effectiveness and expand the role of multidisciplinary tumor board?","volume":"11","author":"Lani","year":"2025","journal-title":"Hepatoma Res"},{"key":"R55-20260618","first-page":"10","article-title":"The interaction effect between key autophagy-related biomarkers and HBV\/HCV infections on the survival prognosis of hepatocellular carcinoma","volume":"11","author":"Wang","year":"2025","journal-title":"Hepatoma Res"},{"key":"R56-20260618","doi-asserted-by":"crossref","DOI":"10.1111\/acel.13666","article-title":"Rapamycin\/metformin co-treatment normalizes insulin sensitivity and reduces complications of metabolic syndrome in type 2 diabetic mice","volume":"21","author":"Reifsnyder","year":"2022","journal-title":"Aging Cell"},{"key":"R57-20260618","article-title":"Novel hypoxia-associated gene signature depicts tumor immune microenvironment and predicts prognosis of colon cancer patients","volume":"13","author":"Xu","year":"2022","journal-title":"Front Genet"},{"key":"R58-20260618","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1007\/s10555-019-09806-4","article-title":"The plasminogen activator inhibitor-1 paradox in cancer:A mechanistic understanding","volume":"38","author":"Kubala","year":"2019","journal-title":"Cancer Metastasis Rev"}],"container-title":["Chinese Medical Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/CM9.0000000000004121","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T07:00:24Z","timestamp":1781766024000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/CM9.0000000000004121"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,17]]},"references-count":58,"URL":"https:\/\/doi.org\/10.1097\/cm9.0000000000004121","relation":{},"ISSN":["0366-6999","2542-5641"],"issn-type":[{"value":"0366-6999","type":"print"},{"value":"2542-5641","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,17]]},"assertion":[{"value":"2025-12-23","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}}]}}